Cellular localization, expression and regulation of neuropeptide Y in kidneys of hypertensive rats

Regulatory Peptides

Volumn 82, Issue 1-3, 1999, Pages 35-43

  Haefliger, Jacques Antoine ^a   Waeber, Bernard ^b   Grouzmann, Eric ^b   Braissant, Olivier ^b   Nussberger, Jürg ^b   Nicod, Pascal ^a   Waeber, Gérard ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Blood pressure; Deoxycorticosterone; Hypertension; Neuropeptide Y; Plasma renin activity

Indexed keywords

DEOXYCORTICOSTERONE ACETATE; NEUROPEPTIDE Y;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; HYPERTENSION; KIDNEY; NONHUMAN; NORTHERN BLOTTING; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT;

ANIMALS; BODY WEIGHT; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEMODYNAMIC PROCESSES; HYPERTENSION, RENAL; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY DISEASES; NEUROPEPTIDE Y; RATS; RATS, WISTAR; RENIN; RNA, MESSENGER;

ANIMALIA;

EID: 0033031716     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(99)00031-2     Document Type: Article

References (41)

1. Michel M.C., Rascher W. Neuropeptide Y: a possible role in hypertension? J Hypertension. 13:1995;385-395.
2. Tatemoto K., Carlquist M., Mutt V. Neuropeptide Y a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature. 296:1982;659-660.
3. Gray T.S., Morley J.E. Neuropeptide Y: anatomical distribution and possible function in mammalian nervous system. Life Sci. 38:1986;389-401.
4. Grouzmann E., Alvarez-Bolado G., Meyer C., Osterheld M.C., Burnier M., Brunner H.R., Waeber B. Localization of neuropeptide Y and its C-terminal flanking peptide in human renal tissue. Peptides. 15:(8):1994;1377-1382.
5. McDonald J.K. NPY and related substance. Crit Rev Neurobiol. 4:1988;97-135.
6. Rohner-Jeanrenaud F., Jeanrenaud B. Obesity, leptin, and the brain. N Engl J Med. 334:1996;281-285.
7. Jamal H., Jones P.M., Byrne J., Suda K., Ghatei M.A., Kanse S.M., Bloom S.R. Peptide contents of neuropeptide Y, vasoactive intestinal polypeptide, and β-calcitonin gene related peptide and their messenger ribonucleic acids after dexamethasone treatment in the isolated rat islets of Langerhans. Endocrinology. 129:1991;3372-3380.
8. Pfister A., Waeber B., Nussberger J., Brunner H.R. Neuropeptide Y normalizes renin secretion in adrenalectomized rats without changing blood pressure. Life Sci. 39:1986;2161-2167.
9. Aubert J.-F., Burnier M., Waeber B., Nussberger J., Dipette D.J., Burris J.F., Brunner H.R. Effects of a nonpressor dose of neuropeptide Y on cardiac output, regional blood flow distribution and plasma renin, vasopressin and catecholamine levels. J Pharmacol Exp Ther. 244:(3):1988;1109-1115.
10. McDermott B.J., Millar B.C., Piper H.M. Cardiovascular effects of neuropeptide Y: receptor interactions and cellular mechanisms. Cardiovasc Res. 27:1993;893-905.
11. Hackenthal E., Aktories K., Jakobs K.H., Lang R.E. Neuropeptide Y inhibits renin release by a pertussis toxin-sensitive mechanism. Am J Physiol. 252:1987;F543-F550.
12. Waeber B., Evéquoz D., Aubert J.-F., Flückiger J.-P., Juillerat L., Nussberger J., Brunner H.R. Prevention of renal hypertension in the rat by neuropeptide Y. J Hypertension. 8:1990;21-25.
13. Waeber B., Burnier M., Nussberger J., Brunner H.R. Role of atrial natriuretic peptides and neuropeptide Y in blood pressure regulation. Horm Res. 34:1990;161-165.
14. Ohtomo Y., Meister B., Hökfelt T., Aperia A. Coexisting NPY and NE synergistically regulate renal tubular Na,K-ATPase activity. Kidney Int. 45:1994;1606-1613.
15. Bischoff A., Michel M.C. Renal effects of neuropeptide Y. Pflügers Arch-Eur J Physiol. 435:1998;443-453.
16. Bischoff A., Avramidis P., Erdbrügger W., Münter K., Michel M.C. Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y. Br J Pharmacol. 120:1997;1335-1343.
17. Allen J.M., Raine A.E.G., Ledingham J.G.G., Bloom S.R. Neuropeptide Y: a novel renal peptide with vasoconstrictor and natriuretic activity. Clin Sci. 68:1985;373-377.
18. Allen J.M., Godfrey N.P., Yeats J.C., Bing R.F., Bloom S.R. Neuropeptide Y in renovascular models of hypertension. Clin Sci. 70:1986;485-488.
19. Goldblatt H., Lynch J., Hanzal R.F., Summerville W.W. Studies on experimental hypertension, production of persistent elevation of systolic blood pression by means of renal ischemia. J Exp Med. 59:1934;347-379.
20. Gavras H., Brunner H.R., Larah J.H., Vaughn E.D., Koss M., Cote L.J., Gavras I. Malignant hypertension resulting from deoxycorticosterone acetate and salt excess. Circ Res. 36:1975;300-309.
21. Price J.S., Kenny A.J., Huskisson N.S., Brown M.J. Neuropeptide Y (NPY) metabolism by endopeptidase-2 hinders characterization of NPY receptors in rat kidney. Br J Pharmacol. 104:1991;321-326.
22. Grouzmann E., Aubert J.-F., Waeber B., Brunner H.R. A sensitive and specific two-site, sandwich-amplified enzyme immunoessay for neuropeptide Y. Peptides. 13:1992;1049-1054.
23. Braissant O., Foufelle F., Scotto C., Dauça M., Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, -β, and -δ in the adult rat. Endocrinology. 137:1996;354-366.
24. Braissant O., Wahli W. A simplified in situ hybridization protocol using non radioactively labelled probes to detect abundant and rare mRNAs on tissue sections. Biochemica. 1:1998;10-16.
25. Waeber G., Thompson N., Waeber B., Brunner H.R., Nicod P., Grouzmann E. Neuropeptide Y expression and regulation in a differentiated rat insulin-secreting cell line. Endocrinology. 133:(3):1993;1061-1067.
26. Flückiger J.P., Gremaud G., Waeber B., Kulik A., Ichino A., Nussberger J., Brunner H.R. Measurement of sympathetic nerve activity in the unanesthetized rat. J Appl Physiol. 167:1989;250-255.
27. Nussberger J., Fasanella d'Amoro T., Porchet M., Waeber B., Brunner D.B., Brunner H.R., Kler L., Brown A.N., Francis R.J. Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteers. J Cardiovasc Pharmacol. 9:1987;39-44.
28. Chomczinski P., Sacchi N. Single step method of RNA isolation by acid guanidium-thiocyanate-chloroform extraction. Anal Biochem. 162:1987;156-159.
29. Makrides S.C., Mulinari R., Zannis V.I., Gavras H. Regulation of renin gene expression in hypertensive rats. Hypertension. 12:1988;405-410.
30. Haefliger J.-A., Bergonzelli G., Waeber G., Aubert J.-F., Nussberger J., Gavras H., Nicod P., Waeber B. Renin and angiotensin II receptor gene expression in kidneys of renal hypertensive rats. Hypertension. 26:1995;733-737.
31. Higuchi H., Yang H.-Y.T., Sabol S.L. Rat neuropeptide Y precursor gene expression. J Biol Chem. 263:(13):1988;6288-6295.
32. Leenen F.H.H., De Jong W., De Wied D. Renal venous and peripheral plasma renin activity in renal hypertension. Am J Physiol. 225:1973;1513-1518.
33. Levy B.I., Michel J.-B., Salzmann J.-L., Azizi M., Poitevin P., Safar M., Camilleri J.-P. Effects of chronic inhibition of converting enzyme on mechanical and structural properties of arteries in rat renovascular hypertension. Circ Res. 63:1988;227-239.
34. Morishita R., Higaki J., Miyazaki M., Ogihara T. Possible role of the vascular renin-angiotensin system in hypertension and vascular hypertrophy. Hypertension. 19:(2):1992;II-62-7.
35. Von Thun A.M., Vari R.C., El-Dahr S.S., Navar L.G. Augmentation of intrarenal angiotensin II levels by chronic angiotensin II infusion. Am J Physiol. 266:1994;F120-F128.
36. Guan S., Fox J., Mitchell K.D., Navar L.G. Angiotensin and angiotensin converting enzyme tissue levels in two kidney, one-clip hypertensive rats. Hypertension. 20:1992;763-767.
37. Laborie C., Bernet F., Kerckaert J.P., Maubert E., Lesage J., Dupouy J.P. Regulation of neuropeptide Y and its mRNA by glucocorticoids in the rat adrenal gland. Neuroendocrinology. 62:(6):1995;601-610.
38. Larsen P.J., Jessop D.S., Chowdrey H.S., Lightman S.L., Mikkelsen J.D. Chronic administration of glucocorticoids directly upregulates prepro-neuropeptide Y and Y1-receptor mRNA levels in the arcuate nucleus of the rat. J Neuroendocrinol. 6:(2):1994;153-159.
39. Sekihara H. 19-Hydroxyandrostenedione as a new hypertensinogenic agent. J Steroid Biochem. 16:1981;329-331.
40. Minth-Worby C.A. Transcriptional regulation of the human neuropeptide Y gene by nerve growth factor. J Biol Chem. 269:(22):1994;15460-15468.
41. Riordan J.F. Angiotensin II, biosynthesis, molecular recognition, and signal transduction. Cell Mol Neurobiol. 15:(6):1995;637-651.